I have spent the last year + researching over 200 CBD companies and their products. I learned how the CBD is extracted, the difference between IH (Industrial Hemp) and THC producing cannabis that is harvested early, so that is is given the legal term Hemp, but technically it is the marijuana plant, etc. First, I chose not to take CBD orally, because of how the body breaks down CBD, when you digest it, it goes through the liver first, meaning less than 20% of what you take ends up in your body. Very expensive!! With vaping CBD oil about 70% makes it right into your bloodstream. With the CBD wax/shatter/dab, it is the same. So I stopped the oral route altogether. If you would oral or vape (inhaling vapor, no combustion), you want to look to see or email the company to ask how they extract the CND, and ask if they use CBD frown in the US. I highly suggest CBD frown in the US! The old law had people growing it overseas, and shipping it here to be extracted. Make sure no solvents were used to extract the CBD, like Butane. Whatever they tell you about how they extract it, look it up! This is a MUST! The most common ways to extract are via CO2 extraction using cold temperatures sometimes called subcritical or supercritical temperatures, same with ethanol extraction, there is no solvent in that either. Please research online both methods. There are a couple of other methods, one comes to mind, but it does not stay fresh long, and I cannot recall the name, I have not found any products which use that method, which is why I cannot name it. After making sure it is not done with anything dangerous, you want to make sure they have batch lab reports that check for heavy metals, mold, and how much CBD,CBG,CBC, etc is in the product. CBD, Cannabidiol is the most common Cannabinoid found in the marijuana or hemp plant. Did you know that IH contains a very small amount of THC? it is at or under.3%, so it is low, but it does help the CBD work.
"Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. 

The endocannabinoid system is tonically active in control of pain, as demonstrated by the ability of SR141716A (rimonabant), a CB1 antagonist, to produce hyperalgesia upon administration to mice (Richardson et al 1997). As mentioned above, the ECS is active throughout the neuraxis, including integrative functions in the periacqueductal gray (Walker et al 1999a; Walker et al 1999b), and in the ventroposterolateral nucleus of the thalamus, in which cannabinoids proved to be 10-fold more potent than morphine in wide dynamic range neurons mediating pain (Martin et al 1996). The ECS also mediates central stress-induced analgesia (Hohmann et al 2005), and is active in nociceptive spinal areas (Hohmann et al 1995; Richardson et al 1998a) including mechanisms of wind-up (Strangman and Walker 1999) and N-methyl-D-aspartate (NMDA) receptors (Richardson et al 1998b). It was recently demonstrated that cannabinoid agonists suppress the maintenance of vincristine-induced allodynia through activation of CB1 and CB2 receptors in the spinal cord (Rahn et al 2007). The ECS is also active peripherally (Richardson et al 1998c) where CB1 stimulation reduces pain, inflammation and hyperalgesia. These mechanisms were also proven to include mediation of contact dermatitis via CB1 and CB2 with benefits of THC noted systemically and locally on inflammation and itch (Karsak et al 2007). Recent experiments in mice have even suggested the paramount importance of peripheral over central CB1 receptors in nociception of pain (Agarwal et al 2007)

If you live with chronic pain, you may have experienced how it can disrupt sleep and, in some cases, can contribute to anxiety and depression. Natural therapies, including exercising and taking up mind-body practices like meditation and yoga, and following an anti-inflammatory diet may help improve quality of life for some people who experience pain regularly.


The use of cannabis for pain relief dates back to ancient China, according to a report published in the journal Cannabis and Cannabinoid Research. It’s thought that CBD oil might help ease chronic pain in part by reducing inflammation. In addition, CBD oil is said to promote sounder sleep and, in turn, treat sleep disruption commonly experienced by people with chronic pain.
Hemp and Marijuana come form the same plant family, but are completely different in function, cultivation and application. Marijuana generally has a high level of THC (a psychoactive compound that makes you feel “high”) and is used for medicinal or recreational purpose. Hemp contains a negligible amount of THC (but is high in CBD) and is used in dietary supplements, skin products, clothing and paper.
This product is not for use by or sale to persons under the age of 18. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. A Doctor's advice should be sought before using this and any supplemental dietary product. All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse this product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. By using this site you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void Where Prohibited By Law.
^ Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM (December 2005). "Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract". Ther Drug Monit. 27 (6): 799–810. PMID 16306858.
Cannabidiol Life of allcbdoilbenefits.com pledges to respect the FDA laws and any/all legal requirements for medical information confidentiality as well as all personal information, including identity, and this will apply to the country and state of the site visitor’s location. Visitors of this site must agree to the terms of our disclaimer & privacy policy or they should not use allcbdoilbenefits.com at all and should kindly leave immediately.
Medical marijuana has fewer risks than other pain-relief medications such as codeine. It also offers more benefit while providing similar pain-relief effects. Since the reactions are incredibly variable and risks of any adverse effect are very low, it is best to discuss options for your pain management with a medical professional and begin with a small dose as a trial. Select the most suitable option for your needs, and let the results quickly manifest themselves.
A. When a product is in violation of the FD&C Act, FDA considers many factors in deciding whether or not to initiate an enforcement action. Those factors include, among other things, agency resources and the threat to the public health. FDA also may consult with its federal and state partners in making decisions about whether to initiate a federal enforcement action.
CBD directly interacts with a number of proteins in the body and central nervous system, a few of which are components of the endogenous cannabinoid system. For instance, CBD binds to both the CB1 and CB2 cannabinoid receptors, but it binds in a way that sets off a reaction that is essentially the opposite of what THC does. CBD is an inverse agonist, while THC is an agonist at CB1. Simply put, CBD is not intoxicating; at the molecular level, it does the opposite of what THC does. Our bodies have several other receptor proteins that participate in the endogenous cannabinoid system (GPR3, GPR6, TRPV1 and TRPV2, for example). CBD binds to all of these, and many of its anti-inflammatory and pain-relieving effects may occur through these pathways.

In 1988, the first cannabinoid receptor was identified (CB1) (Howlett et al 1988) and in 1993, a second was described (CB2) (Munro et al 1993). Both are 7-domain G-protein coupled receptors affecting cyclic-AMP, but CB1 is more pervasive throughout the body, with particular predilection to nociceptive areas of the central nervous system and spinal cord (Herkenham et al 1990; Hohmann et al 1999), as well as the peripheral nervous system (Fox et al 2001; Dogrul et al 2003) wherein synergy of activity between peripheral and central cannabinoid receptor function has been demonstrated (Dogrul et al 2003). CB2, while commonly reported as confined to lymphoid and immune tissues, is also proving to be an important mediator for suppressing both pain and inflammatory processes (Mackie 2006). Following the description of cannabinoid receptors, endogenous ligands for these were discovered: anandamide (arachidonylethanolamide, AEA) in 1992 in porcine brain (Devane et al 1992), and 2-arachidonylglycerol (2-AG) in 1995 in canine gut tissue (Mechoulam et al 1995) (Figure 1). These endocannabinoids both act as retrograde messengers on G-protein coupled receptors, are synthesized on demand, and are especially active on glutamatergic and GABA-ergic synapses. Together, the cannabinoid receptors, their endogenous ligands (“endocannabinoids”) and metabolizing enzymes comprise the endocannabinoid system (ECS) (Di Marzo et al 1998), whose functions have been prosaically termed to be “relax, eat, sleep, forget and protect” (p. 528). The endocannabinoid system parallels and interacts at many points with the other major endogenous pain control systems: endorphin/enkephalin, vanilloid/transient receptor potential (TRPV), and inflammatory. Interestingly, our first knowledge of each pain system has derived from investigation of natural origin analgesic plants, respectively: cannabis (Cannabis sativa, C. indica) (THC, CBD and others), opium poppy (Papaver somniferun) (morphine, codeine), chile peppers (eg, Capsicum annuum, C. frutescens, C. chinense) (capsaicin) and willow bark (Salix spp.) (salicylic acid, leading to acetylsalicylic acid, or aspirin). Interestingly, THC along with AEA and 2-AG, are all partial agonists at the CB1 receptor. Notably, no endocannabinoid has ever been administered to humans, possibly due to issues of patentability and lack of commercial feasibility (Raphael Mechoulam, pers comm 2007). For an excellent comprehensive review of the endocannabinoid system, see Pacher et al (2006), while Walker and Huang have provided a key review of antinociceptive effects of cannabinoids in models of acute and persistent pain (Walker and Huang 2002).


A: No, you will not fail a drug test. All our Zatural products are 3rd party tested to ensure that no THC is present in the oil. We only sell products that register as ND (Not Detected) or 0. Most drug tests are testing for THC levels. However, cheaper drug testing may be testing a wider variety of cannabinoids as they may not be specific enough to test for THC only. It is always a good idea to discuss with your employer or whomever before hand and explain that you are considering taking Hemp Oil or CBD oil. We can provide the tests showing there is no THC present.
If you’re looking into CBD oil for sale, our NEW high potency full spectrum CBD oil is exactly what your body ordered. This hemp oil comes more dominant and stronger than our regular CBD oil online products and provides even faster relief. This high volume boost of potency is available in 500 mg and 1000 mg of cannabinoids, and you will quickly realize why sometimes less is more. Supply your overall mental and physical health with a CBD upgrade. This CBD oil is the same great quality you have come to expect from Kats Botanicals, but with an extra kick. Our high potency full spectrum hemp oil is made with pesticide free, non-GMO industrial hemp oil, extracted from the mature stalks and stems of the hemp plant.
In 1988, the first cannabinoid receptor was identified (CB1) (Howlett et al 1988) and in 1993, a second was described (CB2) (Munro et al 1993). Both are 7-domain G-protein coupled receptors affecting cyclic-AMP, but CB1 is more pervasive throughout the body, with particular predilection to nociceptive areas of the central nervous system and spinal cord (Herkenham et al 1990; Hohmann et al 1999), as well as the peripheral nervous system (Fox et al 2001; Dogrul et al 2003) wherein synergy of activity between peripheral and central cannabinoid receptor function has been demonstrated (Dogrul et al 2003). CB2, while commonly reported as confined to lymphoid and immune tissues, is also proving to be an important mediator for suppressing both pain and inflammatory processes (Mackie 2006). Following the description of cannabinoid receptors, endogenous ligands for these were discovered: anandamide (arachidonylethanolamide, AEA) in 1992 in porcine brain (Devane et al 1992), and 2-arachidonylglycerol (2-AG) in 1995 in canine gut tissue (Mechoulam et al 1995) (Figure 1). These endocannabinoids both act as retrograde messengers on G-protein coupled receptors, are synthesized on demand, and are especially active on glutamatergic and GABA-ergic synapses. Together, the cannabinoid receptors, their endogenous ligands (“endocannabinoids”) and metabolizing enzymes comprise the endocannabinoid system (ECS) (Di Marzo et al 1998), whose functions have been prosaically termed to be “relax, eat, sleep, forget and protect” (p. 528). The endocannabinoid system parallels and interacts at many points with the other major endogenous pain control systems: endorphin/enkephalin, vanilloid/transient receptor potential (TRPV), and inflammatory. Interestingly, our first knowledge of each pain system has derived from investigation of natural origin analgesic plants, respectively: cannabis (Cannabis sativa, C. indica) (THC, CBD and others), opium poppy (Papaver somniferun) (morphine, codeine), chile peppers (eg, Capsicum annuum, C. frutescens, C. chinense) (capsaicin) and willow bark (Salix spp.) (salicylic acid, leading to acetylsalicylic acid, or aspirin). Interestingly, THC along with AEA and 2-AG, are all partial agonists at the CB1 receptor. Notably, no endocannabinoid has ever been administered to humans, possibly due to issues of patentability and lack of commercial feasibility (Raphael Mechoulam, pers comm 2007). For an excellent comprehensive review of the endocannabinoid system, see Pacher et al (2006), while Walker and Huang have provided a key review of antinociceptive effects of cannabinoids in models of acute and persistent pain (Walker and Huang 2002).

While it was originally believed that THC is a breakdown product of CBD, it is now known that both THC and CBD are actually metabolites of their decarboxylated acidic forms, THCa and CBDa. These acidic precursors are decarboxylated (essentially dried) by heat or extraction to produce THC and CBD; only then do they become psychoactive.The compound has medicinal benefits without the “high” that some patients do not desire. This makes CBD appealing to patients who are looking for an alternative to their current meds, which often have opiate-like effects.
I’ve been making a healing cream with CBD oil and other natural oils, so far my customers love it, they claim healing and pain relief. Healing of open wounds with hematoma symptoms erased and zero scabing. Healing psoriasis, eczema with skin returning to a renew elastic softness to skin and no flare ups. I made it for diabetes nephropathy and numbing in my feet. I have a 6 month old tummy tuck, with relief in scar tissue pain.
As for phytocannabinoid-rich hemp oil, due to the presence of the hemp plant’s cannabinoids there are many additional uses and benefits with practically zero side effects. The most common use of this type of hemp oil is for chronic pain management, but many people also use it to treat some symptoms of cancer, among other diseases and conditions. Even the Food and Drug Administration recently approved a new CBD-based prescription medication.

Physiological manifestations like stress, and poor diet may negatively impact other systems in the body via specific cellular processes. Nutrition plays an important role in preserving various systemic and metabolic functions by supplying the appropriate dietary needs to the body system. The nutrient signaling pathways are coupled to cellular processes, and the cross-talk between the two is critical in maintaining a well-balanced systemic function of the body. The systemic imbalance may occur under circumstances such as stress, and fatigue, which may trigger inflammatory responses in the body3 and inflammation may cause unwanted health conditions. It has been shown that various dietary components may support key resolution pathways to inflammation, energy balance and metabolism via the ECS.4,5,6,7,8 Nutrients that may support healthy inflammatory response include omega-3 fatty acids, and antioxidants, from a whole food matrix in the form of phytonutrients.2,9
This product was recommended for me by a friend and I couldnt be happier that we talked about this. Ive had very minor issues with anxiety from work or personal life. By taking this in the morning it really has helped me with those feelings and allowed me to enjoy my day and focus more. Its had a significant affect on my personal life and work because of it. Will be recommending to all my friends who have similar issues.
We are sorry our blog post didn’t answer the question you were looking for. The answer to your question is, that the best product that can assist with chronic pain is a product that contains Cannabinoids in it. Full spectrum hemp oils contain those cannabinoids your body needs to fight pain, stress, anxiety, inflammation and sleep. If your chronic pain is severe, you will want a product that contains a large amount of Cannabinoids.
The second method of pain relief centers around the damage you do when you work out. When you strength train, you create micro-tears in your muscles, which is why you feel sore as you heal. Once your immune cells detect damage, they release inflammatory mediators in order to repair the tissue. CBD, though has the ability to limit the release of some proinflammatory signals, thereby helping with pain without thwarting the healing entirely, Gerdeman explains. 
×